Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2004 Jun;13(3):195–199. doi: 10.1080/09511920410001713501

Effect of influenza vaccinations on immune response and serum eotaxin level in patients with allergic bronchial asthma.

Karina Jahnz-Rózyk 1, Lidia B Brydak 1, Tomasz Targowski 1, Magdalena Machała 1, Tadeusz Plusa 1
PMCID: PMC1781554  PMID: 15223611

Abstract

BACKGROUND: One of the most promising markers of allergic inflammation is eotaxin, which has a selective influence on the migration of eosinophils. Its serum content significantly correlates with the intensity of allergic symptoms, so it might be interesting to know whether vaccination has any influence on serum expression of this chemokine. AIMS: Comparison of the humoral response to influenza vaccine and post-vaccination changes in the serum eotaxin level in patients with allergic bronchial asthma and healthy controls. METHODS: Forty-two asthmatics and 45 healthy individuals were vaccinated with a single dose of influenza subunit vaccine (Influvac). The serum eotaxin level and the antibody response to haemagglutinin (HI) and neuraminidase (NI) glycoproteins were measured before and after vaccination. RESULTS: A significant increase of geometric mean titres of HI and NI was observed in both groups. There were no significant differences between the groups in meanfold increase of HI and NI titres, response rate and protective level of HI. After vaccination, a significant decrease of the mean serum eotaxin value was observed in patients with asthma (149.4 +/- 71.0 versus 125.1 +/- 67.0, p= 0.0017), while no similar effect was present in healthy individuals (153.4 +/- 56.9 versus 159.3 +/- 54.4, p= 0.5). CONCLUSIONS: The results indicate that in patients with allergic bronchial asthma influenza vaccinations assure efficient protective antibody level and modulate the serum level of eotaxin.

Full Text

The Full Text of this article is available as a PDF (313.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ada G. L., Jones P. D. The immune response to influenza infection. Curr Top Microbiol Immunol. 1986;128:1–54. doi: 10.1007/978-3-642-71272-2_1. [DOI] [PubMed] [Google Scholar]
  2. Banks J., Bevan C., Fennerty A., Ebden P., Walters E. H., Smith A. P. Association between rise in antibodies and increase in airway sensitivity after intramuscular injection of killed influenza virus in asthmatic patients. Eur J Respir Dis. 1985 Apr;66(4):268–272. [PubMed] [Google Scholar]
  3. Brown J. R., Kleimberg J., Marini M., Sun G., Bellini A., Mattoli S. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Immunol. 1998 Nov;114(2):137–146. doi: 10.1046/j.1365-2249.1998.00688.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brydak L. B., Machala M. Humoral immune response to influenza vaccination in patients from high risk groups. Drugs. 2000 Jul;60(1):35–53. doi: 10.2165/00003495-200060010-00004. [DOI] [PubMed] [Google Scholar]
  5. Brydak L. B., Roszkowska-Blaim M., Machala M., Leszczyńska B., Sieniawska M. Antibody response to influenza immunization in two consecutive epidemic seasons in patients with renal diseases. Vaccine. 2000 Aug 1;18(28):3280–3286. doi: 10.1016/s0264-410x(00)00126-2. [DOI] [PubMed] [Google Scholar]
  6. Davies J. R., Grilli E. A. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol Infect. 1989 Apr;102(2):325–333. doi: 10.1017/s0950268800030004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. EICKHOFF T. C., SHERMAN I. L., SERFLING R. E. Observations on excess mortality associated with epidemic influenza. JAMA. 1961 Jun 3;176:776–782. doi: 10.1001/jama.1961.03040220024005. [DOI] [PubMed] [Google Scholar]
  8. Gorse G. J., Otto E. E., Daughaday C. C., Newman F. K., Eickhoff C. S., Powers D. C., Lusk R. H. Influenza virus vaccination of patients with chronic lung disease. Chest. 1997 Nov 5;112(5):1221–1233. doi: 10.1378/chest.112.5.1221. [DOI] [PubMed] [Google Scholar]
  9. Groothuis J. R., Lehr M. V., Levin M. J. Safety and immunogenicity of a purified haemagglutinin antigen in very young high-risk children. Vaccine. 1994 Feb;12(2):139–141. doi: 10.1016/0264-410x(94)90051-5. [DOI] [PubMed] [Google Scholar]
  10. Hassan W. U., Henderson A. F., Keaney N. P. Influenza vaccination in asthma. Lancet. 1992 Jan 18;339(8786):194–194. doi: 10.1016/0140-6736(92)90274-7. [DOI] [PubMed] [Google Scholar]
  11. Hossny E., Aboul-Magd M., Bakr S. Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children. Allergy. 2001 Oct;56(10):996–1002. doi: 10.1034/j.1398-9995.2001.00169.x. [DOI] [PubMed] [Google Scholar]
  12. Jose P. J., Griffiths-Johnson D. A., Collins P. D., Walsh D. T., Moqbel R., Totty N. F., Truong O., Hsuan J. J., Williams T. J. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med. 1994 Mar 1;179(3):881–887. doi: 10.1084/jem.179.3.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Krakauer T., Russo C. Serum cytokine levels and antibody response to influenza vaccine in the elderly. Immunopharmacol Immunotoxicol. 2001 Feb;23(1):35–41. doi: 10.1081/iph-100102565. [DOI] [PubMed] [Google Scholar]
  14. Lilly C. M., Nakamura H., Belostotsky O. I., Haley K. J., Garcia-Zepeda E. A., Luster A. D., Israel E. Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. Am J Respir Crit Care Med. 2001 Jun;163(7):1669–1675. doi: 10.1164/ajrccm.163.7.9812044. [DOI] [PubMed] [Google Scholar]
  15. Lilly C. M., Woodruff P. G., Camargo C. A., Jr, Nakamura H., Drazen J. M., Nadel E. S., Hanrahan J. P. Elevated plasma eotaxin levels in patients with acute asthma. J Allergy Clin Immunol. 1999 Oct;104(4 Pt 1):786–790. doi: 10.1016/s0091-6749(99)70288-5. [DOI] [PubMed] [Google Scholar]
  16. Matikainen S., Pirhonen J., Miettinen M., Lehtonen A., Govenius-Vintola C., Sareneva T., Julkunen I. Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virology. 2000 Oct 10;276(1):138–147. doi: 10.1006/viro.2000.0542. [DOI] [PubMed] [Google Scholar]
  17. McElhaney J. E., Upshaw C. M., Hooton J. W., Lechelt K. E., Meneilly G. S. Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults. Vaccine. 1998 Nov;16(18):1742–1747. doi: 10.1016/s0264-410x(98)00133-9. [DOI] [PubMed] [Google Scholar]
  18. Miyamasu M., Misaki Y., Yamaguchi M., Yamamoto K., Morita Y., Matsushima K., Nakajima T., Hirai K. Regulation of human eotaxin generation by Th1-/Th2-derived cytokines. Int Arch Allergy Immunol. 2000 May;122 (Suppl 1):54–58. doi: 10.1159/000053634. [DOI] [PubMed] [Google Scholar]
  19. Monto A. S. Influenza: quantifying morbidity and mortality. Am J Med. 1987 Jun 19;82(6A):20–25. doi: 10.1016/0002-9343(87)90556-0. [DOI] [PubMed] [Google Scholar]
  20. Morita A., Shimosako K., Kikuoka S., Taniguchi Y., Kitaura M., Sasakura K., Tamaki M., Tsuji T., Teraoka H., Yoshie O. Development of a sensitive enzyme-linked immunosorbent assay for eotaxin and measurement of its levels in human blood. J Immunol Methods. 1999 Jun 24;226(1-2):159–167. doi: 10.1016/s0022-1759(99)00066-6. [DOI] [PubMed] [Google Scholar]
  21. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986 Apr 1;136(7):2348–2357. [PubMed] [Google Scholar]
  22. Nicholson K. G., Kent J., Ireland D. C. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993 Oct 16;307(6910):982–986. doi: 10.1136/bmj.307.6910.982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nicholson K. G. Socioeconomics of influenza and influenza vaccination in Europe. Pharmacoeconomics. 1996;9 (Suppl 3):75–78. doi: 10.2165/00019053-199600093-00017. [DOI] [PubMed] [Google Scholar]
  24. Ouellette J. J., Reed C. E. Increased response of asthmatic subjects to methacholine after influenza vaccine. J Allergy. 1965 Nov-Dec;36(6):558–563. doi: 10.1016/0021-8707(65)90193-0. [DOI] [PubMed] [Google Scholar]
  25. Taha R. A., Minshall E. M., Miotto D., Shimbara A., Luster A., Hogg J. C., Hamid Q. A. Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):476–483. doi: 10.1016/s0091-6749(99)70474-4. [DOI] [PubMed] [Google Scholar]
  26. Van Hoecke C., Prikazsky V., Utö I., Menschikowski C. Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients. Gerontology. 1996;42(4):190–198. doi: 10.1159/000213792. [DOI] [PubMed] [Google Scholar]
  27. Wierenga E. A., Snoek M., de Groot C., Chrétien I., Bos J. D., Jansen H. M., Kapsenberg M. L. Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients. J Immunol. 1990 Jun 15;144(12):4651–4656. [PubMed] [Google Scholar]
  28. Yamada H., Yamaguchi M., Yamamoto K., Nakajima T., Hirai K., Morita Y., Sano Y., Yamada H. Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum. Allergy. 2000 Apr;55(4):392–397. doi: 10.1034/j.1398-9995.2000.00474.x. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES